When Hollywood starts investing in peptides, it’s not a trend — it’s the future.
Vanessa Hudgens isn’t just using peptides. She’s betting her money on them. As an investor in Superpower — a health technology company that raised $30 million in its Series A round — Hudgens is part of a growing wave of celebrity investors who see peptide wellness as the next massive market opportunity.
And based on the numbers, they’re probably right.
What Is Superpower?
Superpower (superpower.com) is a health technology platform that combines comprehensive biomarker testing, AI-powered health recommendations, and access to peptides and other advanced therapies. Think of it as the intersection of personalized medicine and consumer wellness — the kind of platform that makes cutting-edge health tools accessible to regular people.
The company raised $30 million in Series A funding led by Forerunner Ventures, with Hudgens among several notable celebrity investors. They’ve raised $42 million total and are actively expanding their peptide offerings.
What makes Superpower interesting isn’t just the celebrity backing — it’s the model. They’re not just selling supplements. They’re providing the full stack: testing to identify what your body actually needs, AI recommendations based on your specific biomarkers, and access to therapies (including peptides) that are tailored to your biology.
Why Celebrities Are Investing in Peptides
The celebrity peptide investment trend is accelerating:
This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any peptide therapy or skincare regimen.
gatlan.com/?_ef_transaction_id=&oid=1&affid=23″ target=”_blank” rel=”noopener sponsored”>Gatlan — a full men’s health platform centered on peptide therapies
These aren’t endorsement deals. These are equity positions. When celebrities put their own money into peptide companies, it signals a level of conviction that goes far beyond a sponsored Instagram post.
The Superpower Model
What Hudgens backed with Superpower represents the next evolution of peptide wellness:
First generation: Individual peptides sold through niche providers to biohackers
Second generation: Celebrity-backed peptide brands with specific product lines
Third generation (Superpower): AI-driven platforms that test, recommend, and deliver personalized peptide protocols
This progression mirrors what happened in fitness (gyms to apps to AI coaches) and nutrition (supplements to meal kits to personalized nutrition). Peptides are following the same curve, just a few years behind.
What This Means for You
The investment wave means more resources pouring into peptide research, better products, more accessible pricing, and more mainstream acceptance. When $42 million flows into a single peptide platform, it attracts attention from researchers, regulators, and other investors — creating a positive cycle that benefits everyone interested in peptide wellness.
It also means the “wild west” phase of peptides is ending. Companies like Superpower are building the infrastructure for a regulated, accessible, data-driven peptide industry. That’s good for consumers who want quality and safety, even if it changes the landscape for the DIY biohacking community.
The Takeaway
Vanessa Hudgens isn’t just a pretty face attached to a wellness brand. She’s an investor who put real money behind a vision of the future where peptide therapy is personalized, data-driven, and accessible. That future is arriving faster than most people realize.
This article is for educational purposes only. Consult with a healthcare provider for personalized health recommendations.
Sources: Forbes, Superpower press materials, Series A announcement, Business Insider
Ready to Start Your Peptide Journey?
Finding a qualified provider is the most important first step. Gatlan connects you with licensed telehealth professionals who specialize in peptide therapy — so you can get expert guidance, proper protocols, and pharmaceutical-grade peptides prescribed safely.
